Director Kevin Kotler resigns from Heron Therapeutics board effective Dec 31, 2023

HERON THERAPEUTICS, INC. /DE/

Kevin Kotler resigned from the Board, effective December 31, 2023.
Resignation not due to any disagreements with the company's operations, policies or practices.
No replacement named at this time.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kevin Kotler

member of the board of directors

HRTX · HERON THERAPEUTICS, INC. /DE/

Effective: 2023-12-31
Filed: December 21, 2023, 6:59 PM ET

On December 20, 2023, Kevin Kotler resigned as a member of the board of directors (the “Board”) of Heron Therapeutics, Inc. (the “Company”), effective December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin Kotler resigned as member of the board of directors at HERON THERAPEUTICS, INC. /DE/.

Action: resigned
Role: member of the board of directors

Exact text from the filing

On December 20, 2023, Kevin Kotler resigned as a member of the board of directors (the “Board”) of Heron Therapeutics, Inc. (the “Company”), effective December 31, 2023.

View on SEC.gov

HERON THERAPEUTICS, INC. /DE/ filing history →

Source: SEC EDGAR

accession 0001193125-23-301337

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.